K. Zier

发表

Retroviral vector-mediated gamma-interferon gene transfer into tumor cells generates potent and long lasting antitumor immunity.

E. Gilboa, K. Cronin, B. Gansbacher, 1990, Cancer research.

Retroviral gene transfer induced constitutive expression of interleukin-2 or interferon-gamma in irradiated human melanoma cells.

E. Gilboa, K. Cronin, B. Gansbacher, 1992, Blood.

Retroviral gene transfer induced constitutive expression of interleukin-2 or interferon-gamma in irradiated human melanoma cells.

E. Gilboa, K. Cronin, B. Gansbacher, 1992, Blood.

T-cell responses to multiple antigens presented by RNA-transfected APCs: a possible immunomonitoring tool

K. Zier, S. Bartido, 2004, Cancer Immunology, Immunotherapy.

Resection of Solid Tumors Reverses T Cell Defects and Restores Protective Immunity1

K. Zier, G. Martinelli, S. Salvadori, 2000, The Journal of Immunology.

Post-transcriptional regulation of MHC class II expression in human T cells.

B. Gansbacher, K. Zier, S. Salvadori, 1992, Cellular immunology.

Negative signal transmission through class II molecules on activated T cells.

K. Zier, N. Urban, 1991, Human immunology.

Regulation of HLA-DR, DP, and DQ expression in activated T cells.

B. Gansbacher, K. Zier, 1988, Cellular immunology.

Low interleukin-2 synthesis by type 1 diabetics is regulated at the pretranslational level.

K. Zier, L. Baker, U. Shah, 1991, Clinical immunology and immunopathology.

Tumour cell vaccines that secrete interleukin-2 (IL-2) and interferonγ (IFN-γ) are recognised by T cells while resisting destruction by natural killer (NK) cells

B. Gansbacher, K. Zier, 1996 .

Defects and Restores Protective Immunity Resection of Solid Tumors Reverses T Cell

K. Zier, G. Martinelli, S. Salvadori, 2000 .

B7-1 amplifies the response to interleukin-2-secreting tumor vaccines in vivo, but fails to induce a response by naive cells in vitro.

B. Gansbacher, K. Zier, S. Tirelli, 1995, Human gene therapy.

Retroviral vector-mediated cytokine-gene transfer into tumor cells.

B. Gansbacher, F. Rosenthal, K. Zier, 1993, Cancer investigation.

The response pattern of human T cells to stimulation following expansion in IL-2.

J. Cutilli, K. Zier, U. Shah, 1991, Immunological investigations.

Expression of HLA-DR mRNA in T cells following activation is early and can precede DNA synthesis.

R. Kennett, N. Ikegaki, B. Gansbacher, 1989, Autoimmunity.

Functional and antigenic properties of cultured T cells in the cell mediated lympholysis (CML) assay.

K. Zier, 1982, Human immunology.

Generation of antigen specific cytotoxic T lymphocytes (CTL) directed against class II molecules expressed by activated T cells.

K. Zier, 1985, Journal of immunological methods.

Antigen presentation by B7-nonprofessional APC does not prevent responses to solid tumor cells.

T. Moran, K. Zier, S. Salvadori, 1998, Cellular immunology.

Heterogeneity ofHLA defined in PLT: A cellular assay detects differences not seen using HLA-DRw serology

B. Gänsbacher, E. Albert, K. Zier, 2005, Immunogenetics.

Generation of discriminatory PL against HLA-D antigens not detected by serology.

B. Gansbacher, K. Zier, 1981, Human immunology.

A Comparative Study of the Buoyant Density Distribution of Normal and Malignant Lymphocytes

C. Huber, D. Lutz, H. Braunsteiner, 1978, British journal of haematology.

Expression of class II antigens by subsets of activated T cells.

K. Zier, 1986, Cellular immunology.

Generation of anti-allogeneic cytotoxic T lymphocytes depends upon a signal, not delivered by tumor cells, that can be provided in trans in the presence of exogenous interleukin-2

K. Zier, S. Salvadori, 1999, Cancer Immunology, Immunotherapy.

Human tumor vaccines and genetic engineering of tumors with cytokine and histocompatibility genes to enhance immunogenicity

B. Gansbacher, F. Rosenthal, K. Zier, 1994, Current opinion in oncology.

Surrogate markers of antitumor responses: in vitro activation of T cells by autologous tumor peptides.

J. Maddux, L. Eisenbach, J. Mandeli, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

IFNgamma secretion following stimulation with total tumor peptides from autologous human tumors.

J. Maddux, L. Eisenbach, J. Mandeli, 2000, Journal of immunological methods.

The use of cytotoxic T cell lines to detect the segregation of a human minor alloantigen within families.

G. Pierson, K. Zier, W. Elkins, 1983, Human immunology.

The control of class II expression on T cells is independent of the regulation of Tac and the induction of proliferation

K. Zier, S. Cohen, S. Salvadori, 1991, Clinical and experimental immunology.

Abnormal signal transduction by T cells of mice with parental tumors is not seen in mice bearing IL-2-secreting tumors.

B. Gansbacher, K. Zier, S. Salvadori, 1994, Journal of immunology.

Susceptibility of human neuroblastoma cell lines to cytotoxic T lymphocyte-mediated lysis

V. Brown, G. Pierson, K. Zier, 1990, Journal of Neuroimmunology.

Linear density gradient separation of human lymphocyte subsets

C. Huber, H. Braunsteiner, K. Zier, 1977, European journal of immunology.

Restimulation in Secondary MLC by Autologous Non‐T Cells

C. Huber, H. Braunsteiner, K. Zier, 1979, Scandinavian journal of immunology.

The detection of human minor alloantigens following restriction determinant implantation.

D. Volsky, F. Sinangil, K. Zier, 1987, Human immunology.

Cell Mediated Immunity: Separation of Cells Involved in Recognitive and Destructive Phases

F. Bach, P. Sondel, K. Zier, 1973, Science.

Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity

E. Gilboa, K. Cronin, B. Gansbacher, 1990, The Journal of experimental medicine.

Decreased Synthesis of Interleukin-2 (IL-2) in Insulin-dependent Diabetes Mellitus

R. Spielman, R S Spielman, K S Zier, 1984, Diabetes.

IL-2 gene therapy of solid tumors: an approach for the prevention of signal transduction defects in T cells

B. Gansbacher, K. Zier, 1996, Journal of Molecular Medicine.

The impact of gene therapy on T cell function in cancer.

B. Gansbacher, K. Zier, 1995, Human gene therapy.

Preventing abnormalities in signal transduction of T cells in cancer: the promise of cytokine gene therapy.

B. Gansbacher, K. Zier, S. Salvadori, 1996, Immunology today.

The effects of gamma interferon on the natural killer and tumor cells of children with neuroblastoma. A preliminary report

R. Kennett, N. Ikegaki, L. Lampson, 1989, Cancer.

Recognition of human minor alloantigen(s) by cytotoxic lymphocytes in vitro

G. Pierson, W. Negendank, K. Zier, 2004, Immunogenetics.

FRACTIONATION OF HUMAN LYMPHOCYTES ON LINEAR DENSITY GRADIENTS

C. Huber, H. Braunsteiner, K. Zier, 1977 .

Cytotoxic T lymphocyte lines (CTLL) against a human minor alloantigen

G. Pierson, K. Zier, W. Elkins, 2004, Immunogenetics.

Linear density gradient separation of human lymphocyte subsets. II. Characterization of cells responding in secondary MLC and CML.

C. Huber, H. Braunsteiner, K. Zier, 1979, Cellular immunology.

Restimulation in secondary MLC by a non-D-locus determinant within the MHC

C. Huber, E. Albert, H. Braunsteiner, 1978, Immunogenetics.

Generation of CTL lines using cultured T cells (CTC) as feeder cells. I. Specificity for class I determinants.

L. Israel, K. Zier, 1984, Human immunology.

The nature of cells responding in mixed leukocyte cultures and cell-mediated lympholysis.

F. Bach, P. Sondel, K. Zier, 1973, Transplantation proceedings.

Priming against Stimulator‐derived Alloantigens Bound onto MLC‐activated Blasts

B. Gänsbacher, K. Zier, E. Albert, 1980, Scandinavian journal of immunology.

Secondary Responses of Human Lymphocytes to Alloantigens In Vitro

F. Bach, K. Zier, 1975, Scandinavian journal of immunology.

Secondary cell-mediated lympholysis: importance of H-2 LD and SD factors

F. Bach, P. Sondel, C. Grillot‐Courvalin, 1976, The Journal of experimental medicine.

DR4 and DQw3: Antigen Report of the Cellular Studies of the Tenth International Histocompatibility Workshop

K. Lundin, J. Hansen, M. Thomsen, 1989 .

Crossreactivity in PLT: the specificity of primed lymphocytes (PL) depends upon the HLA haplotypes of the priming cell and responder.

E. Albert, S. Scholz, K. Zier, 1979, Transplantation proceedings.

T-cell Clones Recognizing Shared or Cross-Reactive Epitopes: Antigen Report of the Cellular Studies of the Tenth International Histocompatibility Workshop

J. Hansen, N. Flomenberg, D. Eckels, 1989 .

DR2: Antigen Report of the Cellular Studies of the Tenth International Histocompatibility Workshop

N. Flomenberg, D. Eckels, A. Zeevi, 1989 .

Presentation of Class I antigens on T cells can induce the generation of antigen-specific CTL.

K. Zier, A. Pickard, 1985, Journal of immunology.

HLA class II mRNA accumulation by activated human T cells following growth in conditioned medium.

B. Gansbacher, K. Zier, 1989, Clinical and experimental immunology.

DISSOCIATION OF FUNCTIONAL RESPONSES OF LYMPHOCYTE SUBPOPULATIONS

F. Bach, K. Zier, 1976 .

Secondary T-Cell Cytotoxicity: Role of LD and SD Antigens

C. Grillot‐Courvalin, K. Zier, M. Bach, 1976 .

Molecular basis of T cell dysfunction in cancer is influenced by the paracrine secretion of tumor-derived IL-2.

K. Zier, S. Salvadori, 1996, Journal of immunology.

Tumor-bearing animals contain suppressed antitumor effectors the function of which can be unmasked by IL-2.

F. Rosenthal, K. Zier, S. Salvadori, 1993, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.

Cell-mediated immune responses between HLA-identical siblings: recognition of antigenic changes associated with acute myelogenous leukaemia.

C. Huber, H. Braunsteiner, K. Zier, 1980, Clinical and experimental immunology.